Literature DB >> 25233075

Exclusive development of a single type of keratinocyte skin cancer: evidence from an Australian population-based cohort study.

Ulrike Keim1, Jolieke C van der Pols2, Gail M Williams3, Adèle C Green4.   

Abstract

Whether susceptible people develop both basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) or one type exclusively during life is unknown. We investigated this in an Australian community cohort of 1,191 adults aged 25-75 years by recording all new BCCs and SCCs for 16 years in people with no previous keratinocyte cancer. Among those who developed multiple skin cancers, age- and sex-specific incidence rates per 100,000 were calculated for those who developed BCC exclusively, SCC exclusively, or BCC and SCC. Corresponding relative risks (and 95% confidence intervals) were estimated by Poisson regression. During follow-up, 116 people developed multiple keratinocyte cancers: 65 (56%) developed BCC exclusively (range 2-8 per person); 18 (16%) developed SCC exclusively (2-5 per person); and 28% developed both types. Of the 116, 88 had a BCC first, of whom 74% subsequently developed only BCCs, and 28 had SCC first, of whom 64% subsequently developed only SCCs. Incidence rates did not differ by sex in the BCC-only, SCC-only, or mixed groups, but they increased significantly with age especially in the SCC-only group. These findings suggest that the majority of people are prone to develop one type rather than a mix of keratinocyte cancers.

Entities:  

Mesh:

Year:  2014        PMID: 25233075     DOI: 10.1038/jid.2014.410

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  23 in total

1.  Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985.

Authors:  Margaret P Staples; Mark Elwood; Robert C Burton; Jodie L Williams; Robin Marks; Graham G Giles
Journal:  Med J Aust       Date:  2006-01-02       Impact factor: 7.738

2.  Simultaneous assessment of risk factors for malignant melanoma and non-melanoma skin lesions, with emphasis on sun exposure and related variables.

Authors:  N Dubin; B S Pasternack; M Moseson
Journal:  Int J Epidemiol       Date:  1990-12       Impact factor: 7.196

3.  The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare.

Authors:  A K Joseph; T L Mark; C Mueller
Journal:  Dermatol Surg       Date:  2001-11       Impact factor: 3.398

4.  Cumulative risks and rates of subsequent basal cell carcinomas in the Netherlands.

Authors:  S C Flohil; S Koljenović; E R M de Haas; L I H Overbeek; E de Vries; T Nijsten
Journal:  Br J Dermatol       Date:  2011-10       Impact factor: 9.302

5.  Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis.

Authors:  I Marcil; R S Stern
Journal:  Arch Dermatol       Date:  2000-12

6.  Clinical signs of photodamage are associated with basal cell carcinoma multiplicity and site: a 16-year longitudinal study.

Authors:  Naomi M Richmond-Sinclair; Nirmala Pandeya; Gail M Williams; Rachel E Neale; Jolieke C van der Pols; Adèle C Green
Journal:  Int J Cancer       Date:  2010-12-01       Impact factor: 7.396

7.  Skin cancer in a subtropical Australian population: incidence and lack of association with occupation. The Nambour Study Group.

Authors:  A Green; D Battistutta; V Hart; D Leslie; D Weedon
Journal:  Am J Epidemiol       Date:  1996-12-01       Impact factor: 4.897

8.  Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.

Authors:  Hermina C Wisgerhof; Jeroen R J Edelbroek; Johan W de Fijter; Geert W Haasnoot; Frans H J Claas; Rein Willemze; Jan N Bouwes Bavinck
Journal:  Transplantation       Date:  2010-05-27       Impact factor: 4.939

9.  The effect of skin examination surveys on the incidence of basal cell carcinoma in a Queensland community sample: a 10-year longitudinal study.

Authors:  Patricia Casarolli Valery; Rachel Neale; Gail Williams; Nirmala Pandeya; Greg Siller; Adèle Green
Journal:  J Investig Dermatol Symp Proc       Date:  2004-03

10.  The Nambour Skin Cancer and Actinic Eye Disease Prevention Trial: design and baseline characteristics of participants.

Authors:  A Green; D Battistutta; V Hart; D Leslie; G Marks; G Williams; P Gaffney; P Parsons; L Hirst; C Frost
Journal:  Control Clin Trials       Date:  1994-12
View more
  3 in total

1.  Cohort studies (and skin cancer) never come alone.

Authors:  Joris A C Verkouteren; Robert J T van der Leest; Tamar Nijsten
Journal:  J Invest Dermatol       Date:  2015-03       Impact factor: 8.551

2.  JID VisualDx Quiz: March 2015.

Authors:  Andrew Ross; Robert S Kirsner
Journal:  J Invest Dermatol       Date:  2015-03       Impact factor: 8.551

3.  Associations of keratinocyte cancers with snp variants in the sonic hedgehog pathway.

Authors:  Astrid J Rodriguez-Acevedo; Annika Antonsson; Upekha E Liyanage; Maria Celia Hughes; Scott Gordon; Jolieke van der Pols; Adele C Green
Journal:  BMC Cancer       Date:  2022-05-03       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.